This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
There are a lot of VERY knowledgable people in here that will be more than glad to give you their two cents. I am just answering quickly in case you are still reading and you know someone has written back!
How do you know that you have NO liver damage? did you have a biopsy (bx)?
If you have NO damage then it sounds like you can wait a while until you get settled in before starting tx. Of course your doctor knows best and none of us are doctors.
If you do "wait" please make sure to have regular testing done - you didn't mention your ALT and AST but with a vl of 13mil being high they would be useful to know. You don't want to wait until your liver is really damaged before you treat.
And they do say that the earlier you treat after infection...the better for you.
Perhaps you can put down a bit more information in here and the smarty pants will help you out.
I just wanted to let you know someone answered and that we care.
Best of luck
Debby
Again, it is only a suggestion, and it should be discussed thoroughly with your doc, but you seem to be in good shape so far.
Also, genotype is important. Geno 2 and 3 need half the treatment time or less than geno 1. Geno 1 is much harder to treat with current therapy. Good luck, and stay well.
PS: ALT is a marker of liver injury, AST is less specific as it can be elevated due to liver, muscle, heart, etc. injury.
Also, have them check your platelets.
My Viral count is 53,800,000 there is hope. I just started treatment (tx) with little side effects (sx). Get more than one doctors opinion and do your research. Get your CBC (Complete Blood Count) too. That will tell you your ALT and AST along with other information.
Check out these sites:
http://www.hcvadvocate.org/
http://www.hepeducate.org/pe_test/pe_course_list.php
http://www.allabouthepatitisc.com/readytolearn/
http://www.hepatitisdoctor.com/
http://www.using-pegasys.com/
Do you know how and how long you have had HCV (Hep C Virus)?
I hope to hear back from you soon.
GIG,
Red
IF YOU DECIDE TO TAKE TREATMENT YOU MAY CONSIDER TAKING IT BEFORE STARTING A NEW CAREER. ALSO FIND OUT WHAT GENONE TYPE YOU ARE. IF YOU ARE A 2 THE DOSES ARE LOWER AND TREATMENT ONLY LASTS FOR 24 WEEKS NOT 48 LIKE GENO 1.
ALT AND AST ECT. ARE LIVER CHEMICAL LEVELS AND ARE A GOOD INDICATOR OF THE CURRENT HEALTH OF YOU LIVER. SVR IS SUSTAINED VIRAL RESPONSE (CURED).
GOOD LUCK AND BE INFORMED. IT IS YOUR HEALTH.
SOUNDS LIKE YOU HAVE A GREAT LIFE IN FRONT OF YOU.
BOBBY
http://www.hivandhepatitis.com/2005icr/aasld/docs/111405_d.htmlOBBY
http://www.pegasys.com/basics/default.asp
You may also ask your doctor regarding two supplements he insists I stay on. One is Sam-E, the other is Milk Thistle.
Good luck and get started on treatment as soon as you can, because you may be one of the fortunate ones that will clear once and for all...
Magnum
Shot 22/out of 24 done.
Good luck to you
Our immune systems respond to a viral infection in a series of events, one of the first of which can be the release of interferons as a barrier in an attempt to block or slow the spread of the virus by interfering with the process of replication - Hence the name Interferon. Then the hunt is on by the rest of the immune system components to seek & try to destroy the virus. (Antibodies, NK-natural killer cells, T cells, ..) Quite unsuccessfully, I might add. This virus is incredibly elusive. It seems that after a year of interfering with replication, circulating virus' levels drop to below detectable amounts (<50 ppmu) and the virus seems to quit trying or goes dormant in `Responders'. However, 10 -15 year follow-up of earliest clinical trial participants/responders and samples taken
from them revealed a high level of relapse and low level activity in others. The virus RNA was still completely in tact in cells and capable of fully functional replication in all participants tested. Recently, highly sensitive electron microscopy revealed virion (virion: A complete virus particle with its DNA or RNA core and protein coat as it exists outside the cell. (also called a viral particle.) Particles embedded in tissue samples taken from cadaveric participants from multiple organs and tissues, which contain the entire code of the virus and are able to develop into fully functional and active virus. We have this virus and we are able to transmit it to others for life.
Interferon alphas seemed to be the most specific to this virus so Pharmaceutical giant Roche patented interferon alpha 2a and the other, Shering Plough patented IFN alpha 2b. Patients had to have injections at least 3 times per week (or daily) for 24 to 48 weeks.
Compliance was a problem because a lot of patients couldn't continue that long and would quit and consequently fail treatment. To make the therapy more convenient, both companies wrapped each molecule with a polymer (polyethyleneglycol – also used in antifreeze, runways, tires – for it's excellent coating and thermal dynamics capabilities) I'm sure a lot of you agree that our modern plastic packaging of our groceries or chocolate bars can be quite frustrating to open sometimes. It's a lot of extra work for our bodies to unwrap or break down the plastic before it can use the raw interferon inside. The interferon still builds up to therapeutic levels in our systems but the pegylated versions take longer to break down so injections are only necessary once a week. My queries to several large insurance providers suggest that close to 50% of those treating do not finish. Insurance providers are exerting huge pressure on the pharms to increase the numbers that complete treatment using the threat of placing restrictions on those who are prescribing. Review panels etc. are some of the suggestions I have heard to date to increase the numbers of patients from 50% of those treating to a higher number, as current treatments are very expensive, but do not at this time impact insurance providers formulary projections, as the number treating is an insignificant percentage at this time but growing.
Human Genome Sciences on the other hand, took a more compassionate approach to the patient and human body and did it more in a way that would be familiar and acceptable to the body and spliced the interferon onto the correct gene of human albumen. Albuferon™ is currently in clinical trials, shows fewer and less extreme side effects and adverse events, shows a good response rate even for genotype 1 with the added benefit of only one injection per month. It can circulate in the blood stream for a long time without breaking down, yet is readily available for use when needed. Albumen is produced naturally in the human body. It's quite nice, friendly stuff – (compare to egg white). Raw interferon can be like putting a crushed aspirin in your mouth – pretty shockingly bitter and harsh, but put the aspirin in a teaspoon of honey and it goes down quite nicely. Stan Shusbank and others working out of Princeton University formed a company Interferon Sciences, which did most of the work on natural production of interferon for HCV. McMaster University in Hamilton Ontario, is far along in sequencing a vaccine for HCV, but, one also has to reminded that what is referred to as subtypes are actually different diseases.
siRNA's are "small interfering RNA" (ribonucleic acid) or nuke – produced by our immune systems in some circumstances that, again, only interfere with the replication process. It is very similar to the virus itself, which is a single strand of RNA protein but the siRNA is harmless yet it plugs or uses exactly the same receptacles that the virus uses to replicate. You could call it a small molecule prophylactic. If the virus can't attach, then it can't replicate. Ribavirin collects in the liver, so any circulating virus' or the ones in the liver would come into close proximity to it and it would have its effect. It is still unclear how Ribavirin works and new discoveries are being made frequently. A few things that are known about Ribavirin are that it can affect almost any genetic material by inducing change or mutation. The virus seems to get looped into a constant mutation cycle until exhausted and consequently, too busy to replicate. Again, it interferes with replication. IF YOU ARE PLANNING TO HAVE CHILDREN OR ARE PREGNANT, DO NOT TAKE RIBAVIRIN.
I strongly feel that Activists, support workers and societies involved or concerned for people with HCV should be insisting that governments and Pharmaceutical companies focus their efforts on developing a vaccine and true cure for this virus instead of focusing on a perpetual market for expensive interfering therapies.
I've always believed in understanding situations with realistic expectations of outcomes. `Eyes wide open', so to speak. Tell it like it is. At least then, we can deal with it in realistic terms.
There are several goals in the treatment of chronic hepatitis C. They include decreasing replication of the virus, decreasing liver inflammation, and slowing the progression to cirrhosis. Stopping detectable viral replication is the main goal of treatment now, since it very likely results in decreased liver inflammation and progression to cirrhosis.
According to most physicians, a “sustained response” to treatment is an absence of detectable hepatitis C virus genetic material in the blood, six months after stopping therapy. Some Doctors, but few researchers equate this with a “cure.” Although not yet rigorously proven, it can be assumed that the persistent absence of hepatitis C virus in the blood indicates that inflammation in the liver has stopped, and potential progression to cirrhosis is no longer a danger. Recent abstracts presented in San Francisco ask the question as to how valuable the validity of red blood cell SVR testing is, as these abstracts concur with studies from Europe dealing with those with continued liver damage with those who have achieved the classic sustained viral response. As a community we need truth, not pharm marketing strategies to enhance our treatment choices. For individuals treatment is either one hundred % effective or zero % effective. There is some indication of fibrosis reversal, but only has been validated for a small minority of patients who have treated and recent abstracts have not had the controls needed to validate these studies, so in my humble opinion are just more pharm hype, that some members of the HCV community have as is so often the case taken and blown way out of proportion and delivered as fact.
I at times wonder who is worse in their evaluations, the pharms or those in the HCV community who do not have the capability or faculty to understand the difference between marketing and evidence based medicine and best practices currently employed in the treatment of HCV. It seems many have the Best in the field, the best on the planet as their own personal Hepatologist. It seems many may actually live in their Docs office as the information their Doc have given them would take hours of their time weekly to discuss all the situations those treating or suffering from HCV endure. A simple rule of thumb would be to disregard those who find the need to dump information on these boards when they use the “my Doc” is considered the best in their field style of preamble prior to the dumping of info.
If you want to be technical, then it is true that no drug "kills" the virus. What the small molecule class does so effectively is, it sticks to the NS 3/4 target which is very, very tiny, uncoats the virus, and allows the immune system to destroy it. The half life of 950 is about equal to the virus, that is another reason why it is so effective.
I was able to work the 72+wks I was on tx, some have to stop working. It can be quite expensive if you do not have good medical insurance also.
We are just people w/ Hep C and there are many many different opinions in here...and you know what they say about opinions....
Cin
Testimonials have been part of quackery since time began.
Assuming that a testimonial comes from a traceable source,you will find:
Patient took convential treatment plus quack remedy.i.e radiotherapy followed by some 'natural' cure.Chooses to credit nice natural remedy rather than harsh medicine for improvement.
Patient is high on placebo effect.
Patient believes they are in remission but do not take tests.Give credit to rhubarb enemas and die nine months later.
All the testimonials I have read for colloidal silver and HVC,I could break down in 30. secs.
Move on to the real issues affecting your health,upon which others have provided good information.
There are a few on the board the same age as you. One woman postponed law school to treat. It is not so bad for a lot of us and awful for others. Much luck to you.
Hey Fresnoborn - that is so cool being a reference librarian. I think it would be a fastinating job. Bet you are good at trivial pursuit (or were until the brain fog took over). I am sure you will be back at it after tx.
frijole
from them revealed a high level of relapse and low level activity in others. "
---------------------------------
My understanding has always been that SVR -- as defined as being non-detec 6-months post treatment -- is durable in the 97-99% range. Not sure if the 10-15 year follow-up study is contradicting those figures or discussing other issues like occult activity. Do you happen to have a link to the study in question. Thanks for any help.
-- Jim
Some of us have continued to work full time effectively, others had to cut down hours, and some have had to stop work altogether. Younger people seem to have lighter side effects so that stands in your favor.
Depending on your genotype you typically will treat for 24 or 48 weeks. If you do decide to treat, definitely have a back up plan for that period of time in case you have to temporarily cut down or leave work.
If you can't live with the possiblity of cutting down or leaving work, then you should seriously consider a watch and wait approach given no liver damage.
-- Jim
Hospitalizations, length of hospital stays, and physician visits for HCV patients have increased by 25% to 30% per year since 1994. There is no breakdown as to the reason a HCV patient presented at a hospital, but from where I sit I can tell you many are treatment or post treatment issues. Quite frankly, I think Hepatitis C is less of a liver disease and more of a blood disease. It affects so, so much more than our livers. In fact, I think by the time we feel it in our liver, it has caused too much damage to our immune system to ever fully recover. HCV needs to be reclassified. It would be interesting to find out how many Fibromyalgia sufferers have been exposed to HCV.
Blanket statements similar to yours do not enhance the debate that this community dearly needs. If one where to hear me speak, I have one basic theme, that this is our disease, we own our individual copies. We own it, why give it away? Unlike the AIDS movement who took back their disease, and own it lock stock and barrel, it seems most within the HCV community are content to let the pharms set the agenda and keep ownership of our disease.
That said, the fact that HCV RNA can persist at levels under the radar of commonly used viral load tests certainly has iimplications that should be studied.
-- Jim
Like you say, all too often we get most of our info from drug company trials and their participating doctors which among other things don't seem very motivated to study the long-term effects of the combo treatment itself.
That said, SVR still seems the best game in town for those with significant liver damage and studies do suggest that SVR can often halt or even reverse fibrosis. As to the implications of any occult virus, that is still to be determined.
As to those with little or no liver damage, I hope they will weigh all points of view before embarking on treatment. Like you suggest, I also think the risks of combo treatment itself are often underplayed by the hep-c medical establishment.
-- Jim
Current studies in Toronto based on genetic markers to predict a successful treatment outcome, hopefully will have some impact on the liaise faire treatment protocols used at present. While this liaise-faire approach may have been appropriate in earlier times, our highly competitive economy demands a more organized and responsive approach to treatment options. Insurance reimbursers are at this time freaking at the cost of treatment combined with the 50% of patients who fail to complete treatment. I am worried that if this trend continues, treatment options for those who really are in need will be difficult to access. At present the costs do not bear significant weight on insurance companies’ profit margins, but they are squawking now. All the numbers and percentages, statistics etc. are from a base of thousands, whereas this list serve and many others there are individuals, real people, with families, employment and quality of life issues. Pharmco economic models are now being designed to reflect individual issues, but at present they do not factor much into the equation. At the end of the day, what I am saying in a nutshell, is that interferon based treatments and those who sell them have hijacked HCV. When one speaks of treatment, they automatically think of interferon based medicines, not the social, economic burden HCV has placed on this community. Not the many other medical manifestations those infected suffer with. One could say there is a huge elephant in the room, but most will not acknowledge its existence.
A couple of weeks ago I was talking to my doc about how many weeks would be optimum for me to treat. After going back and forth about the 36-week rule and the 46-week rule I (didn't even know that one existed LOL ) -- almost as an aside he said that what I really needed was a special blood test to determine what kind of t-cell response I was having.
We didn't have a lot of time to get into the test, but his basic point was (in my mangled words) was that some people during treatment have a profound t-cell response and some only have a spiked response to the interferon. The test can differentiate between the two. Those with spiked responses will tend to relapse. He went on to say that this particular test is only available in a couple of research labs around the world. The tone of his voice was telling -- we just don't really know with what we got to work with today.
But whether it be more study into pre-tx genetic predictors, or more sophisticated early treatment testing like with the t-cells, anything that helps take the guesswork out of tx outcome would be a blessed relief to all of us. It's really hard to plug into the risk/reward equation when we're somewhat uncertain on either.
-- Jim
The statements I made are to the best of my recollection true, and based on many years working in the HCV community, attending and chairing many HCV conferences. Working closely with drug companies and researchers in the HCV field. If you care to debate any of my opinions, by all means please do so. If you are suggesting I just found this stuff on the internet..well enjoy that thought.
By the way, what do you feed your elephant?
I would point out before we remain doom and gloom, is that I would like to see those same studies done with the PI small molecule drugs.
Anyway, I'm a touch busy, have to feed the Corgi's and check on Charles. Being the Queen of England does have its moments.
Have a wonderful day.
One of the studies presenting lower SVR rates in private practice, stated using a length of tx of 29 wks, maybe that plus undercompliance can account for the disparity between theirs and the drug co data?
Then you get the recent study of following up long term svr and the actual SVR rates as measured by the serum rna;
http://www.medpagetoday.com/InfectiousDisease/Hepatitis/tb/2152
and the one I like to read about durability of SVR with no findings of HCV in intrahepatic tissue, plus many other studies showing HCV is not persistent
http://www.natap.org/2005/HCV/010505_02.htm
I guess you can find a study to back almost any claim
I do agree that HCV is the "ignored" illness. Just check the FDA web site. They have all kinds of links dedicated to HIV, but NOT ONE to HCV. I am not objecting to the attention given elsewhere, I just think that HCV deserves it too. Also, there is only one drug in development for HCV that is currently being fast-tracked, and that happened last week with 950.
I would like to see the same studies quoted today 10 years from now with the new class of small molecule drugs. I have a feeling the data might look different. If so, this raises another point: IF there is remnant virus in some compartments like the CNS, AND it can lead to morbidity, AND small molecule drugs can get to these places, (quite a list of assumptions, I know) THEN would it make sense for those who got SVR using current SOC to treat briefly with the newer class of drugs?
That is putting the cart WAY before the horse, but since we are debating it, may as well throw it in there.
One criticism of VX-950 is that it would be taken 3 times per day, and that a once per day drug is much easier, and will be easier to comply with. Also, you don't have to worry about taking every dose at the precise time. As a side note, they haven't ruled out lesser dosing (I guess either in total pills, or maybe twice per day), but that can be an issue, less so the shorter the tx would be. Since 950 so far is best in clinic, some may wonder why other drug companies would START to develop a new drug. The above scenario is exactly why. Once per day with good safety and efficacy is the ultimate, and so far, nothing has shown it can do that. If anyone could develop a drug to do that, it might be king of the therapies.
From my viewpoint, IF 950 and interferon could clear me in a month, I think I would do my very best to make sure I could comply. Can't always control it though.
My wish is that Docs treating the disease, would treat the patient, and rather than using the cure word, would place much more emphasis on the informed consent portion of considering treatment. At present, in my opinion, most who hear the cure word, pay little attention to the side effects, be they short, or long term.
At present there is not much data on the effects of these treatments. There is some info from Europe, where the pharms have a much less influence on treatment messaging. Side effect surveillance is slim to none and slim is on vacation. England's NICE has a 800 number where patients can report side effects. In North America there is too much of a problem for Docs to report all the side effects patients present, and no surveillance methodology for long term effects
========================
I have two minds on this. On one hand there's the selection process used in the studies. But on the other hand many of the trials limit the use of "rescue" drugs, the number of PCR's, and fiddling with the meds, doses and tx time.
-- Jim
I have had HCV probably for 23 years + and I have no liver damage and low viral load. I decided to try treatment now (Im 41 year old) because I had other physical symptoms like joint pains that where slowly incapacitating me. I do not expect to be able to work at all during treatment.! I have lived very exhilarating live, but Iwe had quite healthy life style as I stopped drinking when I was 23.
There is relatively little known about the virus because its so new in our books, and when you think of fx homogenizing of milk, we dont even know the full effect of that on the human body. There are bound to be new drugs on the horizon, but its also going to be years until we know if they have adverse effect. All the best to you, and stick around.